PRELIMINARY RESULTS OF DARATUMUMAB, CYCLOPHOSPHAMIDE, THALIDOMIDE AND DEXAMETHASONE: A QUADRUPLET INTENSIED TREATMENT FOR NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) TRANSPLANT ELIGIBLE (TE) PATIENTS
Crusoé, E.Q., Salvino, M.A., Santos, H.H.M., Santos, A.S., Almeida, A.M., Fonseca, C.A., Leal, J.S., Santos, J.A., Hungria, V.T.M., Arruda, M.G.B.
Published in Hematology, Transfusion and Cell Therapy (01.11.2020)
Published in Hematology, Transfusion and Cell Therapy (01.11.2020)
Get full text
Journal Article
PRELIMINARY RESULTS OF DARATUMUMAB, CYCLOPHOSPHAMIDE, THALIDOMIDE AND DEXAMETHASONE: A QUADRUPLET INTENSIED TREATMENT FOR NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) TRANSPLANT ELIGIBLE (TE) PATIENTS
Crusoé, E.Q., Salvino, M.A., Silva, S.Q., Santos, H.H.M., Santos, A.S., Almeida, A.M., Vieira, L.O., Fonseca, C.A., Lucas, L.F., Leal, J.S., Santos, M.M., Santos, J.A., Adorno, E., Hungria, V.T.M., Arruda, M.G.B.
Published in Hematology, Transfusion and Cell Therapy (01.11.2020)
Published in Hematology, Transfusion and Cell Therapy (01.11.2020)
Get full text
Journal Article
Prevalence of the alteration of the ratio kappa/lambda by Freelite® in blood donors over forty years of age at Santa Casa of São Paulo: Preliminary Analysis
Arruda, M.M, Crusoe, E.Q, Simão, A.Z, Lima, L.C.P, Campos Filho, M.B.M, Traldi, M.C, Brechmacher, G, Cury, P, Desiato, M, Langhi, D.M, Chiattone, C.S, Hungria, V.T.M
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Get full text
Journal Article
Prevalence of oligoclonal bands in multiple myeloma patients who achieved at least very good partial response after treatment with standard or high dose chemotherapy- final analysis
Soarez Vieira da Silva, L, de Queiroz Crusoe, E, de Souza Sampaio Almeida, M, de Sousa, L.R.G, Perez, A.L, Cury, P, Rossato, M, Higashi, F, Silva Dias, A.L.M, de Castro, A.C.M, Chiattone, C.S, Hungria, V.T.M
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Get full text
Journal Article
Impact of Treatment Duration and Dosing on Efficacy and Safety in a Phase 3 Study of Panobinostat Plus Bortezomib and Dexamethasone in Patients With Relapsed or Relapsed and Refractory Multiple Myeloma
San-Miguel, J.F, Hungria, V.T.M, Yoon, S.-S, Beksac, M, Dimopoulos, M.A, Elghandour, A, Jedrzejczak, W.W, Guenther, A, Nakorn, T.N, Siritanaratkul, N, Schlossman, R.L, Hou, J, Moreau, P, Lonial, S, Lee, J.H, Einsele, H, Sopala, M, Redhu, S, Paul, S, Corrado, C, Binlich, F, Richardson, P.G
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Get full text
Journal Article
Subgroup Analysis by Prior Treatment of the Efficacy and Safety of Panobinostat Plus Bortezomib and Dexamethasone in Patients With Relapsed or Relapsed and Refractory Multiple Myeloma in the PANORAMA 1 Study
Richardson, P.G, Hungria, V.T.M, Yoon, S.-S, Beksac, M, Dimopoulos, M.A, Elghandour, A, Jedrzejczak, W.W, Guenther, A, Nakorn, T.N, Siritanaratkul, N, Schlossman, R.L, Hou, J, Moreau, P, Lonial, S, Lee, J.H, Einsele, H, Sopala, M, Bengoudifa, B.R, Corrado, C, San-Miguel, J.F
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Get full text
Journal Article